SCHEMBL5117029

SCHEMBL5117029

N#Cc1cccc(-c2ccc(/C=N/O)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.47
XDH P47989 1/20 0.47
SLC22A12 Q96S37 1/20 0.47
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2A Q12879 2/20 0.44
GRIN2B Q13224 2/20 0.44
GRIN2C Q14957 2/20 0.44
GRIN3A Q8TCU5 2/20 0.44
CLK4 Q9HAZ1 1/20 0.44
ASIC1 P78348 1/20 0.43
MMP12 P39900 1/20 0.42
MMP13 P45452 1/20 0.42
KCNH2 Q12809 1/20 0.42
PGR P06401 3/20 0.42
HDAC8 Q9BY41 1/20 0.41
PDK2 Q15119 1/20 0.41
MAP4K4 O95819 1/20 0.40
PLG P00747 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5117035 1.00 PTPN5 (0.47) PTPN5XDHSLC22A12GRIN2DGRIN3B
SCHEMBL5125595 0.83 KMT2A (0.53)
SCHEMBL5125590 0.83 KMT2A (0.53)
SCHEMBL6279942 0.81 GRIN2D (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2447978 0.81 GRIN2D (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2041049 0.81 GRIN2D (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28881260 0.81 GABRG2 (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29987372 0.81 GABRG2 (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28881256 0.81 GABRG2 (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29936120 0.79 ASIC1 (0.54) ASIC1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR PTPN5 857/4885XDH 852/4885SLC22A12 3503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.